Bleeding risk of surgery and its prevention in patients with inherited platelet disorders

Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complic...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 102; no. 7; pp. 1192 - 1203
Main Authors Orsini, Sara, Noris, Patrizia, Bury, Loredana, Heller, Paula G., Santoro, Cristina, Kadir, Rezan A., Butta, Nora C., Falcinelli, Emanuela, Cid, Ana Rosa, Fabris, Fabrizio, Fouassier, Marc, Miyazaki, Koji, Lozano, Maria Luisa, Zúñiga, Pamela, Flaujac, Claire, Podda, Gian Marco, Bermejo, Nuria, Favier, Remi, Henskens, Yvonne, De Maistre, Emmanuel, De Candia, Erica, Mumford, Andrew D., Ozdemir, Gul Nihal, Eker, Ibrahim, Nurden, Paquita, Bayart, Sophie, Lambert, Michele P., Bussel, James, Zieger, Barbara, Tosetto, Alberto, Melazzini, Federica, Glembotsky, Ana C., Pecci, Alessandro, Cattaneo, Marco, Schlegel, Nicole, Gresele, Paolo
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.07.2017
Subjects
Online AccessGet full text
ISSN0390-6078
1592-8721
1592-8721
DOI10.3324/haematol.2016.160754

Cover

Abstract Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence.
AbstractList Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence.
Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence.Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence.
Author Tosetto, Alberto
Orsini, Sara
Santoro, Cristina
Fabris, Fabrizio
Nurden, Paquita
Cattaneo, Marco
Mumford, Andrew D.
Miyazaki, Koji
Noris, Patrizia
Bury, Loredana
Kadir, Rezan A.
Falcinelli, Emanuela
Flaujac, Claire
Favier, Remi
Henskens, Yvonne
De Maistre, Emmanuel
Cid, Ana Rosa
Melazzini, Federica
Zúñiga, Pamela
Eker, Ibrahim
Lambert, Michele P.
Heller, Paula G.
Glembotsky, Ana C.
Bussel, James
Podda, Gian Marco
Lozano, Maria Luisa
Pecci, Alessandro
De Candia, Erica
Schlegel, Nicole
Butta, Nora C.
Gresele, Paolo
Fouassier, Marc
Bayart, Sophie
Zieger, Barbara
Ozdemir, Gul Nihal
Bermejo, Nuria
AuthorAffiliation 1 Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Italy
15 Department of Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain
3 Hematología Investigación, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, CONICET, Argentina
6 Unidad de Hematología, Hospital Universitario La Paz-IDIPaz, Madrid, Spain
22 Gülhane Military Medical Faculty, Pediatric Hematology Department, Ankara, Turkey
7 Unidad de Hemostasia y Trombosis, Hospital Universitario y Politecnico La Fe, Valencia, Spain
21 Cerrahpasa Medical Faculty, Pediatric Hematology Department, Istanbul, Turkey
16 Assistance Publique-Hôpitaux de Paris, Armand Trousseau Children’s Hospital, French Reference Centre for Inherited Platelet Disorders, Paris, France
10 Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan
25 1 st Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medici
AuthorAffiliation_xml – name: 17 Hematological Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands
– name: 29 Centre de Référence des Pathologies Plaquettaires (CRPP), Service d’Hématologie Biologique, CHU Robert Debré, AP-HP, Paris, France
– name: 18 Department of Biology and Haematology, Centre Hospitalier Universitaire Dijon, France
– name: 26 Department of Pediatrics, Division of Hematology, Weill Cornell Medicine, New York, NY, USA
– name: 3 Hematología Investigación, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, CONICET, Argentina
– name: 20 School of Clinical Sciences, University of Bristol, UK
– name: 5 Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK
– name: 1 Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Italy
– name: 24 Centre Régional de Traitement des Hémophiles, Centre Hospitalier Universitaire de Rennes, France
– name: 2 Department of Internal Medicine, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy
– name: 15 Department of Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain
– name: 4 La Sapienza University of Rome, Italy
– name: 7 Unidad de Hemostasia y Trombosis, Hospital Universitario y Politecnico La Fe, Valencia, Spain
– name: 23 Reference Centre for Platelet Disorders, Bordeaux University Hospital Centre, Rythmology and Cardiac Modeling Institute (LIRYC), Xavier Arnozan Hospital, Pessac, France
– name: 25 1 st Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PN, USA
– name: 19 Hemostasis and Thrombosis Unit, Institute of Internal Medicine, Policlinico Agostino Gemelli-Università Cattolica Sacro Cuore, Rome, Italy
– name: 12 Department of Hematology-Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
– name: 14 Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Italy
– name: 28 Hematology Department, S. Bortolo Hospital, Vicenza, Italy
– name: 9 Consultations d’Hémostase – CRTH, CHU de Nantes, France
– name: 6 Unidad de Hematología, Hospital Universitario La Paz-IDIPaz, Madrid, Spain
– name: 27 Department of Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Germany
– name: 11 Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguery Centro Regional de Hemodonación, IMIB-Arrixaca, Universidad de Murcia, Murcia 30003 and Grupo de Investigación CB15/00055 del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
– name: 16 Assistance Publique-Hôpitaux de Paris, Armand Trousseau Children’s Hospital, French Reference Centre for Inherited Platelet Disorders, Paris, France
– name: 8 Clinica Medica 1 - Medicina Interna CLOPD, Dipartimento Assistenziale Integrato di Medicina, Azienda-Ospedale Università di Padova and Dipartimento di Medicina, Università di Padova, Italy
– name: 21 Cerrahpasa Medical Faculty, Pediatric Hematology Department, Istanbul, Turkey
– name: 10 Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan
– name: 13 Service d’Hématologie Biologique Cochin Hospital, Paris, France
– name: 22 Gülhane Military Medical Faculty, Pediatric Hematology Department, Ankara, Turkey
Author_xml – sequence: 1
  givenname: Sara
  surname: Orsini
  fullname: Orsini, Sara
– sequence: 2
  givenname: Patrizia
  surname: Noris
  fullname: Noris, Patrizia
– sequence: 3
  givenname: Loredana
  surname: Bury
  fullname: Bury, Loredana
– sequence: 4
  givenname: Paula G.
  surname: Heller
  fullname: Heller, Paula G.
– sequence: 5
  givenname: Cristina
  surname: Santoro
  fullname: Santoro, Cristina
– sequence: 6
  givenname: Rezan A.
  surname: Kadir
  fullname: Kadir, Rezan A.
– sequence: 7
  givenname: Nora C.
  surname: Butta
  fullname: Butta, Nora C.
– sequence: 8
  givenname: Emanuela
  surname: Falcinelli
  fullname: Falcinelli, Emanuela
– sequence: 9
  givenname: Ana Rosa
  surname: Cid
  fullname: Cid, Ana Rosa
– sequence: 10
  givenname: Fabrizio
  surname: Fabris
  fullname: Fabris, Fabrizio
– sequence: 11
  givenname: Marc
  surname: Fouassier
  fullname: Fouassier, Marc
– sequence: 12
  givenname: Koji
  surname: Miyazaki
  fullname: Miyazaki, Koji
– sequence: 13
  givenname: Maria Luisa
  surname: Lozano
  fullname: Lozano, Maria Luisa
– sequence: 14
  givenname: Pamela
  surname: Zúñiga
  fullname: Zúñiga, Pamela
– sequence: 15
  givenname: Claire
  surname: Flaujac
  fullname: Flaujac, Claire
– sequence: 16
  givenname: Gian Marco
  surname: Podda
  fullname: Podda, Gian Marco
– sequence: 17
  givenname: Nuria
  surname: Bermejo
  fullname: Bermejo, Nuria
– sequence: 18
  givenname: Remi
  surname: Favier
  fullname: Favier, Remi
– sequence: 19
  givenname: Yvonne
  surname: Henskens
  fullname: Henskens, Yvonne
– sequence: 20
  givenname: Emmanuel
  surname: De Maistre
  fullname: De Maistre, Emmanuel
– sequence: 21
  givenname: Erica
  surname: De Candia
  fullname: De Candia, Erica
– sequence: 22
  givenname: Andrew D.
  surname: Mumford
  fullname: Mumford, Andrew D.
– sequence: 23
  givenname: Gul Nihal
  surname: Ozdemir
  fullname: Ozdemir, Gul Nihal
– sequence: 24
  givenname: Ibrahim
  surname: Eker
  fullname: Eker, Ibrahim
– sequence: 25
  givenname: Paquita
  surname: Nurden
  fullname: Nurden, Paquita
– sequence: 26
  givenname: Sophie
  surname: Bayart
  fullname: Bayart, Sophie
– sequence: 27
  givenname: Michele P.
  surname: Lambert
  fullname: Lambert, Michele P.
– sequence: 28
  givenname: James
  surname: Bussel
  fullname: Bussel, James
– sequence: 29
  givenname: Barbara
  surname: Zieger
  fullname: Zieger, Barbara
– sequence: 30
  givenname: Alberto
  surname: Tosetto
  fullname: Tosetto, Alberto
– sequence: 31
  givenname: Federica
  surname: Melazzini
  fullname: Melazzini, Federica
– sequence: 32
  givenname: Ana C.
  surname: Glembotsky
  fullname: Glembotsky, Ana C.
– sequence: 33
  givenname: Alessandro
  surname: Pecci
  fullname: Pecci, Alessandro
– sequence: 34
  givenname: Marco
  surname: Cattaneo
  fullname: Cattaneo, Marco
– sequence: 35
  givenname: Nicole
  surname: Schlegel
  fullname: Schlegel, Nicole
– sequence: 36
  givenname: Paolo
  surname: Gresele
  fullname: Gresele, Paolo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28385783$$D View this record in MEDLINE/PubMed
BookMark eNp9kkFvVCEUhYmpsdPqPzCGpZs3BR48wIWJNmqbNHGjC1eEB5cZ6pvHCExN_72M0zHWhSvCufd8Nzf3nKGTOc2A0EtKln3P-MXawsbWNC0ZocOSDkQK_gQtqNCsU5LRE7QgvSZdK6hTdFbKLSGMaC2foVOmeiWk6hfo2_sJwMd5hXMs33EKuOzyCvI9trPHsRa8zXAHc41pxnHGW1tj-xX8M9Z1E9aQYwWPt5OtMEHFPpaUPeTyHD0Ndirw4uE9R18_fvhyedXdfP50ffnupnNc8tpxApYRZ4OWlAg3jmT0wAaw2ks5UjcwEqwQY9M4VUEScMSHQJRzgRFP-nN0feD6ZG_NNseNzfcm2Wh-CymvjM01ugmMDqzXWo3OUcql5SpoIp1UXkkeqNSN9fbA2u7GDXjXNs12egR9XJnj2qzSnRFiGAgTDfD6AZDTjx2UajaxOJgmO0PaFUOVElr0XNLW-urvWX-GHG_TGt4cGlxOpWQIxsVq94doo-NkKDH7IJhjEMw-COYQhGbm_5iP_P_afgEM-7xL
CitedBy_id crossref_primary_10_1111_ans_18208
crossref_primary_10_7759_cureus_57345
crossref_primary_10_1055_s_0044_1782519
crossref_primary_10_1016_j_tmrv_2018_05_002
crossref_primary_10_1080_09537104_2024_2380374
crossref_primary_10_1080_09537104_2025_2470758
crossref_primary_10_1016_j_thromres_2022_11_021
crossref_primary_10_3390_jcm9020539
crossref_primary_10_3390_jcm9082508
crossref_primary_10_47717_turkjsurg_2022_4567
crossref_primary_10_3390_ijms22094330
crossref_primary_10_1055_a_1700_7036
crossref_primary_10_1111_bjh_18570
crossref_primary_10_35366_116172
crossref_primary_10_1111_ejh_14198
crossref_primary_10_1111_hae_14986
crossref_primary_10_3390_ijms22094521
crossref_primary_10_1002_rth2_12193
crossref_primary_10_1016_j_jtha_2023_07_006
crossref_primary_10_1007_s12325_020_01453_4
crossref_primary_10_1097_HS9_0000000000000601
crossref_primary_10_1186_s13023_023_02787_2
crossref_primary_10_1155_2020_2342837
crossref_primary_10_1177_1074248419838512
crossref_primary_10_1182_bloodadvances_2020004057
crossref_primary_10_1016_j_pathol_2019_10_005
crossref_primary_10_1126_scitranslmed_aay0203
crossref_primary_10_1182_blood_2020010038
crossref_primary_10_1371_journal_pone_0220625
crossref_primary_10_1002_rth2_12114
crossref_primary_10_1016_j_anrea_2018_10_003
crossref_primary_10_3390_cancers15205049
crossref_primary_10_1016_j_clineuro_2022_107181
crossref_primary_10_1016_j_blre_2020_100784
crossref_primary_10_1016_j_acvd_2018_10_004
crossref_primary_10_1055_s_0041_1728786
crossref_primary_10_1016_j_rpth_2024_102552
crossref_primary_10_1111_trf_17594
crossref_primary_10_1097_MBC_0000000000000719
crossref_primary_10_25284_2519_2078_2_107__2024_308308
crossref_primary_10_1097_EJA_0000000000001803
crossref_primary_10_1016_j_arth_2021_04_024
crossref_primary_10_17533_udea_iatreia_310
crossref_primary_10_1097_MBC_0000000000001045
crossref_primary_10_1016_j_thromres_2019_07_014
crossref_primary_10_3390_hematolrep15030041
crossref_primary_10_1186_s13054_019_2347_3
crossref_primary_10_1111_ijlh_13638
crossref_primary_10_1016_j_jpp_2018_02_003
crossref_primary_10_1111_ijlh_12814
crossref_primary_10_1016_j_rpth_2023_102305
crossref_primary_10_1080_09537104_2020_1745169
crossref_primary_10_1016_j_tracli_2018_07_003
crossref_primary_10_1007_s10815_024_03249_9
crossref_primary_10_1111_bjh_15409
crossref_primary_10_1111_hae_14643
crossref_primary_10_1111_jth_14683
crossref_primary_10_2147_JBM_S271744
crossref_primary_10_1016_j_accpm_2018_10_004
crossref_primary_10_1038_s44161_024_00421_3
crossref_primary_10_3390_jcm12196372
crossref_primary_10_1111_jocs_14354
crossref_primary_10_1177_08971900221119167
crossref_primary_10_1016_j_bja_2018_09_010
crossref_primary_10_3324_haematol_2021_278776
crossref_primary_10_1007_s40140_022_00521_5
crossref_primary_10_1016_S0049_3848_19_30368_8
crossref_primary_10_1016_j_thromres_2019_06_009
crossref_primary_10_1097_HS9_0000000000000286
crossref_primary_10_1111_ijlh_12995
crossref_primary_10_3390_jcm10030533
crossref_primary_10_1016_j_rpth_2024_102334
crossref_primary_10_1002_jbio_202300221
crossref_primary_10_1002_rth2_12374
crossref_primary_10_1055_s_0041_1726344
crossref_primary_10_1097_ACO_0000000000000999
crossref_primary_10_1097_TXD_0000000000001303
crossref_primary_10_3324_haematol_2022_280856
crossref_primary_10_7759_cureus_76233
crossref_primary_10_1080_09537104_2017_1371290
crossref_primary_10_1002_humu_23927
crossref_primary_10_1111_hae_14559
crossref_primary_10_1055_a_1515_0813
crossref_primary_10_1055_a_2462_6609
crossref_primary_10_1080_17474086_2019_1562333
crossref_primary_10_1002_pbc_29622
crossref_primary_10_1530_EOR_22_0054
crossref_primary_10_1055_a_1344_7279
crossref_primary_10_1111_jth_15263
crossref_primary_10_36290_uro_2019_041
ContentType Journal Article
Copyright Copyright© 2017 Ferrata Storti Foundation.
Copyright© 2017 Ferrata Storti Foundation 2017
Copyright_xml – notice: Copyright© 2017 Ferrata Storti Foundation.
– notice: Copyright© 2017 Ferrata Storti Foundation 2017
CorporateAuthor European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders
CorporateAuthor_xml – name: European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3324/haematol.2016.160754
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1592-8721
EndPage 1203
ExternalDocumentID oai_doaj_org_article_9f23998bcc1147a48f907c78d874f179
PMC5566025
28385783
10_3324_haematol_2016_160754
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
29I
2WC
53G
5GY
5RE
5VS
AAFWJ
AAYXX
ADBBV
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GROUPED_DOAJ
H13
HYE
KQ8
OK1
OVT
P2P
RHI
RNS
RPM
SJN
TFS
TR2
UDS
W8F
WOQ
WOW
CGR
CUY
CVF
ECM
EIF
M~E
NPM
RHF
SV3
7X8
5PM
ID FETCH-LOGICAL-c474t-40ea20caf97105cbb0bde26ea9d77b1c620fa55be26418f70ec0dff08ccf20d03
IEDL.DBID DOA
ISSN 0390-6078
1592-8721
IngestDate Wed Aug 27 01:06:05 EDT 2025
Thu Aug 21 13:52:47 EDT 2025
Thu Jul 10 22:43:57 EDT 2025
Wed Feb 19 02:43:00 EST 2025
Thu Apr 24 22:57:49 EDT 2025
Tue Jul 01 04:22:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License Copyright© 2017 Ferrata Storti Foundation.
https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions
Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions
https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-40ea20caf97105cbb0bde26ea9d77b1c620fa55be26418f70ec0dff08ccf20d03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/9f23998bcc1147a48f907c78d874f179
PMID 28385783
PQID 1885953471
PQPubID 23479
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_9f23998bcc1147a48f907c78d874f179
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5566025
proquest_miscellaneous_1885953471
pubmed_primary_28385783
crossref_citationtrail_10_3324_haematol_2016_160754
crossref_primary_10_3324_haematol_2016_160754
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-07-01
PublicationDateYYYYMMDD 2017-07-01
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Italy
PublicationPlace_xml – name: Italy
PublicationTitle Haematologica (Roma)
PublicationTitleAlternate Haematologica
PublicationYear 2017
Publisher Ferrata Storti Foundation
Publisher_xml – name: Ferrata Storti Foundation
References 19657319 - Blood Coagul Fibrinolysis. 2009 Apr;20(3):215-7
23710629 - Transfusion. 2014 Feb;54(2):300-5
12411289 - Blood. 2003 Mar 15;101(6):2089-93
22775395 - Vox Sang. 2012 Nov;103(4):284-93
22583386 - J Oral Pathol Med. 2013 Feb;42(2):115-24
21113246 - Transfus Med Hemother. 2010;37(5):237-246
16307424 - Klin Padiatr. 2005 Nov-Dec;217(6):365-70
20626619 - J Thromb Haemost. 2010 Sep;8(9):2063-5
25899604 - Br J Haematol. 2015 Aug;170(4):559-63
7459811 - Cancer. 1981 Jan 1;47(1):207-14
25403439 - J Thromb Haemost. 2015 Feb;13(2):314-22
24957661 - Transfus Med. 2014 Aug;24(4):213-8
24786773 - Blood. 2014 Jun 26;123(26):4037-44
22398565 - Thromb Haemost. 2012 Jun;107(6):1188-9
26001792 - Haematologica. 2015 Aug;100(8):1038-44
12192307 - Blood Coagul Fibrinolysis. 2002 Sep;13(6):551-3
17107346 - Br J Haematol. 2006 Dec;135(5):603-33
20844233 - Blood. 2010 Dec 23;116(26):5832-7
21953125 - World J Surg. 2011 Dec;35(12):2603-10
15567653 - J Clin Anesth. 2004 Sep;16(6):458-60
23020613 - Platelets. 2012;23 (7):552-63
22510862 - Semin Thromb Hemost. 2012 Apr;38(3):292-8
19882326 - Surg Today. 2009;39(11):1002-5
21670242 - Circulation. 2011 Jun 14;123(23):2736-47
23940247 - Pediatrics. 2013 Sep;132(3):e793-5
24976115 - J Thromb Haemost. 2014 Sep;12(9):1562-9
25068867 - Blood Coagul Fibrinolysis. 2014 Dec;25(8):907-8
19631969 - Thromb Res. 2009 Nov;124(5):e13-8
27484722 - Hamostaseologie. 2016 Nov 7;36(4):265-278
10823254 - Thromb Haemost. 2000 May;83(5):644-7
26962877 - Semin Thromb Hemost. 2016 Apr;42(3):292-305
24763399 - Haematologica. 2014 Aug;99(8):1387-94
16210149 - J Heart Lung Transplant. 2005 Oct;24(10):1697-9
24739923 - J Indian Soc Pedod Prev Dent. 2014 Apr-Jun;32(2):181-4
22188821 - Int J Pediatr Otorhinolaryngol. 2012 Feb;76(2):291-4
17174124 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):626-9
References_xml – reference: 26962877 - Semin Thromb Hemost. 2016 Apr;42(3):292-305
– reference: 21113246 - Transfus Med Hemother. 2010;37(5):237-246
– reference: 17174124 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):626-9
– reference: 25899604 - Br J Haematol. 2015 Aug;170(4):559-63
– reference: 22583386 - J Oral Pathol Med. 2013 Feb;42(2):115-24
– reference: 24957661 - Transfus Med. 2014 Aug;24(4):213-8
– reference: 25068867 - Blood Coagul Fibrinolysis. 2014 Dec;25(8):907-8
– reference: 10823254 - Thromb Haemost. 2000 May;83(5):644-7
– reference: 25403439 - J Thromb Haemost. 2015 Feb;13(2):314-22
– reference: 20626619 - J Thromb Haemost. 2010 Sep;8(9):2063-5
– reference: 16210149 - J Heart Lung Transplant. 2005 Oct;24(10):1697-9
– reference: 22188821 - Int J Pediatr Otorhinolaryngol. 2012 Feb;76(2):291-4
– reference: 22398565 - Thromb Haemost. 2012 Jun;107(6):1188-9
– reference: 24976115 - J Thromb Haemost. 2014 Sep;12(9):1562-9
– reference: 16307424 - Klin Padiatr. 2005 Nov-Dec;217(6):365-70
– reference: 21953125 - World J Surg. 2011 Dec;35(12):2603-10
– reference: 20844233 - Blood. 2010 Dec 23;116(26):5832-7
– reference: 17107346 - Br J Haematol. 2006 Dec;135(5):603-33
– reference: 27484722 - Hamostaseologie. 2016 Nov 7;36(4):265-278
– reference: 23710629 - Transfusion. 2014 Feb;54(2):300-5
– reference: 24739923 - J Indian Soc Pedod Prev Dent. 2014 Apr-Jun;32(2):181-4
– reference: 15567653 - J Clin Anesth. 2004 Sep;16(6):458-60
– reference: 24786773 - Blood. 2014 Jun 26;123(26):4037-44
– reference: 22775395 - Vox Sang. 2012 Nov;103(4):284-93
– reference: 22510862 - Semin Thromb Hemost. 2012 Apr;38(3):292-8
– reference: 19631969 - Thromb Res. 2009 Nov;124(5):e13-8
– reference: 21670242 - Circulation. 2011 Jun 14;123(23):2736-47
– reference: 19657319 - Blood Coagul Fibrinolysis. 2009 Apr;20(3):215-7
– reference: 12192307 - Blood Coagul Fibrinolysis. 2002 Sep;13(6):551-3
– reference: 23020613 - Platelets. 2012;23 (7):552-63
– reference: 23940247 - Pediatrics. 2013 Sep;132(3):e793-5
– reference: 19882326 - Surg Today. 2009;39(11):1002-5
– reference: 26001792 - Haematologica. 2015 Aug;100(8):1038-44
– reference: 7459811 - Cancer. 1981 Jan 1;47(1):207-14
– reference: 12411289 - Blood. 2003 Mar 15;101(6):2089-93
– reference: 24763399 - Haematologica. 2014 Aug;99(8):1387-94
SSID ssj0020997
Score 2.5253258
Snippet Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1192
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Blood Platelet Disorders - complications
Blood Platelet Disorders - congenital
Blood Platelet Disorders - diagnosis
Child
Child, Preschool
Female
Hemorrhage - epidemiology
Hemorrhage - etiology
Hemorrhage - prevention & control
Humans
Incidence
Male
Middle Aged
Patient Outcome Assessment
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Postoperative Complications - prevention & control
Premedication - methods
Risk Assessment
Risk Factors
Surgical Procedures, Operative - adverse effects
Surgical Procedures, Operative - methods
Treatment Outcome
Young Adult
Title Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
URI https://www.ncbi.nlm.nih.gov/pubmed/28385783
https://www.proquest.com/docview/1885953471
https://pubmed.ncbi.nlm.nih.gov/PMC5566025
https://doaj.org/article/9f23998bcc1147a48f907c78d874f179
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_Sg3gR2_qxWiWCeFual2Q3ybEVSxHqyUI9hXzSB8_dR_f14H_vTDbv0SdCL16zWRIyk8xvMjO_EPJJeRWi56IVgXetDDK1TsXUKmeyd9H0XWHgu_reX17LbzfdzYOnvjAnbKYHnhfu1GSsvtQ-BEDuykmdwZ0LSketZAZtwtOXGbZ1pqqrhfWgJX5gwDkCKzgXzQlAD6e3DslQRww7LHq8XFGd3DNKhbv_X4Dz77zJB4bo4gV5XhEkPZtnfkiepOGIHJ8NMNqv3_QzLTmd5bL8iDy9qqHzY_LzfDUbKorZ5HTMdJoroqkbIl1uJrqubE7jQJcDrYSrE8WbWmjAOkFAp3S9AnQKwqax8nZOL8n1xdcfXy7b-q5CG6SSG3AZk-MsuGwAXnTBe-Zj4n1yJirlF6HnLLuu89AmFzorlgKLOTMdQuYsMvGKHAzjkN4Qmk0PDqKQpaIVyey40VxIr01O4BvphojtwtpQScfx7YuVBecDxWG34rAoDjuLoyHt7q_1TLrxSP9zlNmuL1JmlwZQJFsVyT6mSA35uJW4hS2GcRM3pPF-sguNJHACzHhDXs8asBsK0JmGQ080RO3pxt5c9r8My9tC490BkgbE-fZ_TP4decYRb5Q84hNysLm7T-8BLW38h7Ix_gApjRJS
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bleeding+risk+of+surgery+and+its+prevention+in+patients+with+inherited+platelet+disorders&rft.jtitle=Haematologica+%28Roma%29&rft.au=Sara+Orsini&rft.au=Patrizia+Noris&rft.au=Loredana+Bury&rft.au=Paula+G.+Heller&rft.date=2017-07-01&rft.pub=Ferrata+Storti+Foundation&rft.issn=0390-6078&rft.eissn=1592-8721&rft.volume=102&rft.issue=7&rft_id=info:doi/10.3324%2Fhaematol.2016.160754&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_9f23998bcc1147a48f907c78d874f179
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0390-6078&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0390-6078&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0390-6078&client=summon